Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTIC
2301
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $920K | ﹤0.01% |
219,100
-1,900
| -0.9% | -$7.98K |
|
2302
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $919K | ﹤0.01% |
134,300
-15,900
| -11% | -$109K |
|
2303
Star Group
SGU
$389M
| $916K | ﹤0.01% |
70,603
-9,300
| -12% | -$121K |
|
2304
Allegiant Air
ALGT
$1.16B
| $913K | ﹤0.01% |
9,928
-800
| -7% | -$73.6K |
|
2305
Greif Class B
GEF.B
$2.42B
| $911K | ﹤0.01% |
11,900
-1,400
| -11% | -$107K |
|
2306
Berry Corp
BRY
$251M
| $910K | ﹤0.01% |
115,900
-18,200
| -14% | -$143K |
|
2307
Flushing Financial
FFIC
$465M
| $909K | ﹤0.01% |
61,023
-7,300
| -11% | -$109K |
|
2308
Mercer International
MERC
$204M
| $908K | ﹤0.01% |
92,872
-10,900
| -11% | -$107K |
|
2309
Treace Medical Concepts
TMCI
$442M
| $907K | ﹤0.01% |
36,000
-4,100
| -10% | -$103K |
|
2310
Anika Therapeutics
ANIK
$121M
| $905K | ﹤0.01% |
31,500
-3,700
| -11% | -$106K |
|
2311
8x8 Inc
EGHT
$285M
| $904K | ﹤0.01% |
216,900
-43,800
| -17% | -$183K |
|
2312
OraSure Technologies
OSUR
$238M
| $901K | ﹤0.01% |
148,900
-17,700
| -11% | -$107K |
|
2313
Karyopharm Therapeutics
KPTI
$53.8M
| $901K | ﹤0.01% |
15,437
-1,840
| -11% | -$107K |
|
|
AGEN
2314
Agenus
AGEN
$154M
| $900K | ﹤0.01% |
30,167
-1,188
| -4% | -$35.4K |
|
2315
Vitesse Energy
VTS
$999M
| $899K | ﹤0.01% |
+47,244
| New | +$899K |
|
2316
Central Garden & Pet
CENT
$2.28B
| $897K | ﹤0.01% |
27,313
-3,375
| -11% | -$111K |
|
2317
TruBridge
TBRG
$299M
| $897K | ﹤0.01% |
29,700
-4,000
| -12% | -$121K |
|
|
ABST
2318
DELISTED
Absolute Software Corporation Common Stock
ABST
| $889K | ﹤0.01% |
113,800
-10,300
| -8% | -$80.5K |
|
2319
Arrow Financial
AROW
$479M
| $888K | ﹤0.01% |
36,725
-4,326
| -11% | -$105K |
|
2320
Republic Bancorp
RBCAA
$1.49B
| $887K | ﹤0.01% |
20,900
-2,200
| -10% | -$93.3K |
|
2321
Magnachip Semiconductor
MX
$110M
| $884K | ﹤0.01% |
95,300
-12,300
| -11% | -$114K |
|
2322
The RMR Group
RMR
$282M
| $884K | ﹤0.01% |
33,692
-3,700
| -10% | -$97.1K |
|
2323
Business First Bancshares
BFST
$729M
| $881K | ﹤0.01% |
51,408
-6,200
| -11% | -$106K |
|
2324
ARKO Corp
ARKO
$563M
| $880K | ﹤0.01% |
103,661
-12,300
| -11% | -$104K |
|
2325
Excelerate Energy
EE
$759M
| $877K | ﹤0.01% |
39,600
-4,800
| -11% | -$106K |
|